Oral administration of DAEB can increase the relative spleen and thymus weight of tumor-bearing animals, promote secretion of tumor necrosis factor alpha (TNF-α), stimulate lymphocyte proliferation, and augment phagocytosis and secretion of NO and TNF-α in peritoneal macrophages. Here, TNF is linked to neoplasm.